Shire Viropharma Inc (VPHM)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart
Ticker: VPHM Exchange: NSQ


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2012-12-27 2012-12-24 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
17,500 -31.7%
22.53
USD 394,301 		17,500 -31.7% 22.53 USD 394,301
2012-12-17 2012-12-13 S Sale

BROOKE PAUL A

Non-Executive Director
60,000 -36.5%
23.87
USD 1,431,954 		60,000 -36.5% 23.87 USD 1,431,954
2012-12-12 2012-12-10 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
14,999 -28.5%
24.07
USD 360,984 		14,999 -28.5% 24.07 USD 360,984
2012-12-12 2012-12-10 S Sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
50,000 -57.0%
24.07
USD 1,203,360 		50,000 -57.0% 24.07 USD 1,203,360
2012-12-12 2012-12-10 S Sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
10,000 -21.0%
24.07
USD 240,672 		10,000 -21.0% 24.07 USD 240,672
2012-12-05 2012-12-03 S Sale

Wolf John Peter III

VP, General Counsel

Officer
18,000 -100.0%
24.85
USD 447,257 		18,000 -100.0% 24.85 USD 447,257
2012-12-05 2012-12-03 B Purchase

DOUGHERTY MICHAEL R

Non-Executive Director
2,500 +55.6%
25.07
USD 62,675 		2,500 +55.6% 25.07 USD 62,675
2012-12-05 2012-12-03 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
10,000 -18.3%
24.80
USD 248,000 		10,000 -18.3% 24.80 USD 248,000
2012-12-04 2012-11-30 S Sale

GLASER ROBERT

Non-Executive Director
10,000 -19.5%
24.78
USD 247,795 		10,000 -19.5% 24.78 USD 247,795
2012-12-04 2012-11-30 S Sale

GLASER ROBERT

Non-Executive Director
20,000 -32.6%
24.78
USD 495,590 		20,000 -32.6% 24.78 USD 495,590
2012-11-30 2012-11-28 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
15,000 -21.6%
24.22
USD 363,326 		15,000 -21.6% 24.22 USD 363,326
2012-11-30 2012-11-28 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
2,500 -4.4%
24.22
USD 60,554 		2,500 -4.4% 24.22 USD 60,554
2012-11-15 2012-11-13 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
12,500 -18.7%
25.01
USD 312,585 		12,500 -18.7% 25.01 USD 312,585
2012-11-15 2012-11-13 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
10,000 -15.5%
24.84
USD 248,426 		10,000 -15.5% 24.84 USD 248,426
2012-11-13 2012-11-08 S Sale

MILANO VINCENT

President and CEO

Executive Director
41,418 -30.5%
24.54
USD 1,016,522 		41,418 -30.5% 24.54 USD 1,016,522
2012-11-13 2012-11-08 S Sale

MILANO VINCENT

President and CEO

Executive Director
42,000 -30.8%
24.54
USD 1,030,806 		42,000 -30.8% 24.54 USD 1,030,806
2012-11-05 2012-11-02 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
10,000 -15.5%
25.37
USD 253,703 		10,000 -15.5% 25.37 USD 253,703
2012-06-13 2012-06-11 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
10,000 -13.4%
20.04
USD 200,430 		10,000 -13.4% 20.04 USD 200,430
2012-03-27 2012-03-23 PS Planned sale

Pietrusko Robert

VP, Regulatory & Quality

Officer
20,000 -82.9%
30.00
USD 600,000 		20,000 -82.9% 30.00 USD 600,000
2012-03-12 2012-03-09 S Sale

Morris Richard Steven

Chief Accounting Officer

Officer
1,300 -51.1%
29.71
USD 38,618 		1,300 -51.1% 29.71 USD 38,618
2012-03-12 2012-03-09 S Sale

Fletcher Robert C.

V.P., Business Development

Officer
32,000 -99.3%
29.65
USD 948,954 		32,000 -99.3% 29.65 USD 948,954
2012-03-07 2012-03-05 S Sale

Morris Richard Steven

Chief Accounting Officer

Officer
5,300 -81.0%
33.01
USD 174,953 		5,300 -81.0% 33.01 USD 174,953
2012-03-07 2012-03-05 S Sale

DOYLE THOMAS F

VP Strategic Initiatives

Officer
210,000 -80.0%
32.48
USD 6,820,212 		210,000 -80.0% 32.48 USD 6,820,212
2012-03-06 2012-03-01 S Sale

SOLAND DANIEL B

VP, Chief Operating Officer

Officer
30,000 -41.2%
32.99
USD 989,700 		30,000 -41.2% 32.99 USD 989,700
2012-03-05 2012-03-01 S Sale

Rowland Charles A Jr

VP, Chief Financial Officer

Officer
12,750 -42.7%
32.11
USD 409,434 		12,750 -42.7% 32.11 USD 409,434
2012-03-05 2012-03-01 S Sale

Rowland Charles A Jr

VP, Chief Financial Officer

Officer
70,000 -70.1%
32.12
USD 2,248,197 		70,000 -70.1% 32.12 USD 2,248,197
2011-12-16 2011-12-14 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
50,566 +2.6%
27.29
USD 1,379,860 		50,566 +2.6% 27.29 USD 1,379,860
2011-12-16 2011-12-14 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
291,706 +3.1%
27.29
USD 7,960,161 		291,706 +3.1% 27.29 USD 7,960,161
2011-12-16 2011-12-14 B Purchase

14159 capital (GP), LLC

Large shareholder
7,828 +2.6%
27.29
USD 213,613 		7,828 +2.6% 27.29 USD 213,613
2011-12-15 2011-12-14 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
25,000 -56.3%
25.17
USD 629,250 		25,000 -56.3% 25.17 USD 629,250
2011-12-15 2011-12-14 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
25,000 -56.3%
25.50
USD 637,500 		25,000 -56.3% 25.50 USD 637,500
2011-12-14 2011-12-13 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
22,330 -53.5%
23.50
USD 524,755 		22,330 -53.5% 23.50 USD 524,755
2011-12-14 2011-12-12 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
17,670 -47.6%
23.50
USD 415,317 		17,670 -47.6% 23.50 USD 415,317
2011-12-05 2011-12-01 S Sale

DOYLE THOMAS F

VP Strategic Initiatives

Officer
10,000 -16.0%
23.82
USD 238,159 		10,000 -16.0% 23.82 USD 238,159
2011-12-01 2011-11-30 PS Planned sale

Pietrusko Robert

VP, Regulatory & Quality

Officer
20,000 -83.6%
24.00
USD 480,000 		20,000 -83.6% 24.00 USD 480,000
2011-11-29 2011-11-28 PS Planned sale

Pietrusko Robert

VP, Regulatory & Quality

Officer
19,000 -82.9%
23.00
USD 437,000 		19,000 -82.9% 23.00 USD 437,000
2011-11-29 2011-11-28 S Sale

GLASER ROBERT

Non-Executive Director
5,000 -11.9%
23.00
USD 115,000 		5,000 -11.9% 23.00 USD 115,000
2011-11-28 2011-11-23 PS Planned sale

Pietrusko Robert

VP, Regulatory & Quality

Officer
1,000 -25.6%
23.00
USD 23,000 		1,000 -25.6% 23.00 USD 23,000
2011-11-23 2011-11-21 PS Planned sale

MILANO VINCENT

President and CEO

Executive Director
41,691 -35.4%
22.53
USD 939,127 		41,691 -35.4% 22.53 USD 939,127
2011-11-23 2011-11-21 PS Planned sale

MILANO VINCENT

President and CEO

Executive Director
19,996 -20.8%
22.53
USD 450,428 		19,996 -20.8% 22.53 USD 450,428
2011-11-23 2011-11-21 PS Planned sale

MILANO VINCENT

President and CEO

Executive Director
15,000 -16.4%
22.53
USD 337,889 		15,000 -16.4% 22.53 USD 337,889
2011-11-17 2011-11-16 S Sale

Morris Richard Steven

Chief Accounting Officer

Officer
2,000 -63.2%
22.59
USD 45,181 		2,000 -63.2% 22.59 USD 45,181
2011-11-15 2011-11-14 PS Planned sale

Pietrusko Robert

VP, Regulatory & Quality

Officer
20,000 -83.6%
22.00
USD 440,000 		20,000 -83.6% 22.00 USD 440,000
2011-11-09 2011-11-07 S Sale

Wolf John Peter III

VP, General Counsel

Officer
12,250 -100.0%
21.08
USD 258,194 		12,250 -100.0% 21.08 USD 258,194
2011-11-08 2011-11-07 S Sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
200 -1.0%
21.01
USD 4,202 		200 -1.0% 21.01 USD 4,202
2011-11-08 2011-11-07 S Sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
19,800 -50.2%
21.00
USD 415,800 		19,800 -50.2% 21.00 USD 415,800
2011-11-02 2011-11-01 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
24,121 -55.4%
20.05
USD 483,641 		24,121 -55.4% 20.05 USD 483,641
2011-11-02 2011-10-31 S Sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
20,495 -51.3%
20.42
USD 418,555 		20,495 -51.3% 20.42 USD 418,555
2011-10-06 2011-10-05 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
145,763 +1.6%
18.18
USD 2,650,423 		145,763 +1.6% 18.18 USD 2,650,423
2011-10-06 2011-10-05 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
16,278 +0.9%
18.18
USD 295,985 		16,278 +0.9% 18.18 USD 295,985
2011-10-06 2011-10-05 B Purchase

14159 capital (GP), LLC

Large shareholder
6,017 +2.1%
18.18
USD 109,408 		6,017 +2.1% 18.18 USD 109,408
2011-10-06 2011-10-04 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
45,584 +0.5%
17.48
USD 796,644 		45,584 +0.5% 17.48 USD 796,644
2011-10-06 2011-10-04 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
2,511 +0.1%
17.48
USD 43,883 		2,511 +0.1% 17.48 USD 43,883
2011-10-06 2011-10-04 B Purchase

14159 capital (GP), LLC

Large shareholder
1,905 +0.7%
17.48
USD 33,293 		1,905 +0.7% 17.48 USD 33,293
2011-10-03 2011-10-03 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
445,574 +5.0%
17.71
USD 7,890,269 		445,574 +5.0% 17.71 USD 7,890,269
2011-10-03 2011-10-03 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
70,629 +0.8%
17.62
USD 1,244,589 		70,629 +0.8% 17.62 USD 1,244,589
2011-10-03 2011-09-30 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
88,657 +1.0%
18.08
USD 1,602,892 		88,657 +1.0% 18.08 USD 1,602,892
2011-10-03 2011-09-30 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
43,321 +0.5%
18.19
USD 788,122 		43,321 +0.5% 18.19 USD 788,122
2011-10-03 2011-09-30 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
13,576 +0.7%
18.08
USD 245,450 		13,576 +0.7% 18.08 USD 245,450
2011-10-03 2011-09-30 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
6,634 +0.4%
18.19
USD 120,690 		6,634 +0.4% 18.19 USD 120,690
2011-10-03 2011-09-30 B Purchase

14159 capital (GP), LLC

Large shareholder
3,367 +1.2%
18.08
USD 60,874 		3,367 +1.2% 18.08 USD 60,874
2011-10-03 2011-09-30 B Purchase

14159 capital (GP), LLC

Large shareholder
1,645 +0.6%
18.19
USD 29,927 		1,645 +0.6% 18.19 USD 29,927
2011-10-03 2011-09-29 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
159,945 +1.9%
18.00
USD 2,878,882 		159,945 +1.9% 18.00 USD 2,878,882
2011-10-03 2011-09-29 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
21,117 +1.1%
18.00
USD 380,089 		21,117 +1.1% 18.00 USD 380,089
2011-10-03 2011-09-29 B Purchase

14159 capital (GP), LLC

Large shareholder
6,084 +2.2%
18.00
USD 109,507 		6,084 +2.2% 18.00 USD 109,507
2011-10-03 2011-09-29 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
89,970 +1.1%
17.97
USD 1,616,392 		89,970 +1.1% 17.97 USD 1,616,392
2011-10-03 2011-09-29 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
11,878 +0.6%
17.97
USD 213,399 		11,878 +0.6% 17.97 USD 213,399
2011-10-03 2011-09-29 B Purchase

14159 capital (GP), LLC

Large shareholder
3,423 +1.3%
17.97
USD 61,497 		3,423 +1.3% 17.97 USD 61,497
2011-09-26 2011-09-26 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
4,697 +0.3%
18.13
USD 85,155 		4,697 +0.3% 18.13 USD 85,155
2011-09-26 2011-09-26 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
22,084 +1.2%
18.13
USD 400,295 		22,084 +1.2% 18.13 USD 400,295
2011-09-26 2011-09-26 B Purchase

14159 capital (GP), LLC

Large shareholder
1,103 +0.4%
18.13
USD 19,997 		1,103 +0.4% 18.13 USD 19,997
2011-09-26 2011-09-26 B Purchase

14159 capital (GP), LLC

Large shareholder
5,184 +1.9%
18.13
USD 93,965 		5,184 +1.9% 18.13 USD 93,965
2011-09-26 2011-09-26 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
28,000 +0.3%
18.13
USD 507,632 		28,000 +0.3% 18.13 USD 507,632
2011-09-26 2011-09-26 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
131,641 +1.6%
18.13
USD 2,386,125 		131,641 +1.6% 18.13 USD 2,386,125
2011-09-26 2011-09-23 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
8,828 +0.5%
17.78
USD 156,988 		8,828 +0.5% 17.78 USD 156,988
// ... existing code ... // ... rest of the file ...